Competitive Intelligence

Life Science Competition Congress

November 16-17, 2015 | Westin Governor Morris | Morristown, NJ Enhance Competitive and Business Intelligence Platforms While Increasing Insight and Learning Strategies to Win in the Marketplace

STATE OF THE INDUSTRY: COMPETITIVE INTELLIGENCE Competitive intelligence and big data continue to shape and sharpen the pharmaceutical industry, offering considerable insights that can spark meaningful change. An umbrella for gathering, analyzing, organizing and sharing information about a company’s customers, products and, of course, industry competitors, competitive intelligence makes companies smarter. Big data, then, is the mass volume of data that is created every day – via social media, video, internet devices and more – that can eventually be processed and organized to provide valuable insights. Simply put, companies that use data well have an advantage over their competitors. With that in mind, the following is additional information and updates on the latest news regarding competitive intelligence in the life sciences industry. Why Big Data and Competitive Intelligence Add up to More than Just 1+1=2 Anyone working in the life sciences industry today knows that there is a lot of data to collect and analyze – so much so that it can be overwhelming. When big data solutions and competitive intelligence come together, that’s when frustration can turn into a real competitive advantage, namely increased revenue and business productivity. As business leaders seek and find trends, interesting correlations and ways to optimize the business, they quickly learn the value of big data analytics and competitive intelligence in the industry today. The long list of advantages starts with monitoring and potentially reducing risk during clinical trials. Research companies that can quickly get a handle on adverse events and issues during a clinical trial can react promptly, rather than facing serious delays. Big data and competitive intelligence also brings a wealth of information together in an integrated and organized fashion. Whether it’s internal studies and patient information or external data from industry organizations, big data pulls together key insight on clinical and research studies, various initiatives, new drugs and more. Further, it allows companies to make more accurate predictions and enjoy more notable results.

To Register:

866-207-6528 |

www.exlevents.com/competition

BIG DATA CONTINUES TO CHANGE THE WAY COMPANIES DO BUSINESS Thanks to ongoing development and improvements in emerging technology, big data isn’t just for computer geeks – it influences every department in a successful business, providing actionable information and insights for decision-makers. To take advantage of big data and competitive intelligence, companies need to first recognize what information they are looking for and how they might use it. The next step is all about efficiency – the longer data sits in a spreadsheet, the less effective it will be in improving the bottom line. Intelligent information can spark change for organizations willing to do things a little differently, whether it’s updating a specific process, predicting future business trends, or moving forward with a new trial or product. Ultimately, however, it’s people that must take charge of innovative technology. When you bring the right people together with the right technology, positive transformation can take place. Big Data Companies Make Big Headlines Big data continues to be big business. Likewise, big data and competitive intelligence companies are being recognized for their innovative business practices, support of company growth and ability to provide actionable leads. Recently, HG Data, a leader in competitive intelligence for technology, was named a company to watch by Outsell, Inc. in its B2B Trade & Business Information & Company Information: 2015 Market Size, Share, Forecast and Trend report. This report also stated that real-time indicators are more important than ever, that sales enablement platforms that are driven by data are continuing to grow, that quality and quantity are equally important when it comes to competitive intelligence, and that verification is still important in terms of automated data collection. Furthermore, more organizations now provide detailed industry-specific competitive intelligence reporting to help companies stay abreast of the competitive and of new developments. Research and Markets, for instance, recently added a report on Interleukin-17 inhibitors and receptor antagonists as related to inflammatory and autoimmune disease treatments. Such reports provide detailed information for companies working in similar fields and can include drug codes, product categories, target of action, R&D stage and more useful information. Regulatory Intelligence Adds Another Layer to Competitive Intelligence Defined as gathering and analyzing information that is publicly available, regulatory intelligence offers another level of insight. In a recent Regulatory Affairs Professionals Society (RAPs) meeting, Linda Bowen, the head of U.S. regulatory policy for Sanofi discussed the role of regulatory intelligence in regulated industries in front of a record audience. Clearly, this issue is of interest to companies of all sizes. At the RAPS meeting, regulatory intelligence was defined and examined. Bowen noted that monitoring the environment today will provide information to craft policy in the future. This goes beyond sales and marketing and competitive intelligence, which is why most smaller companies lack a regulatory intelligence arm, although this department is beneficial to companies focused on meeting regulations, growth and positive communications.

Upcoming Summit on Competitive Intelligence ExL Pharma’s Life Science Competition Congress will be held on November 16-17 at the Westin Governor Morris Hotel in Morristown, NJ. If you are interested in learning more about this important topic, please visit website for more information or to register.

To Register:

866-207-6528 |

www.exlevents.com/competition